Skip to main content
    U

    Uniqure NV (QURE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $20.78
    -1.10 (-5.03%)

    Market Cap: $1.53B

    Last updated: Nov 17, 2026 at 4:16 PM ET

    Uniqure NV (QURE) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Uniqure NV (QURE) has a market cap of $1.53B and an enterprise value of $1.49B. It kept -1154.84% of revenue as net income over the last 12 months. Its share count is up 19.46% from a year earlier.

    Total Valuation

    Enterprise value is 3.13% below the market cap, as cash exceeds debt.

    Market Cap$1.53B
    Enterprise Value$1.49B
    Latest price (Nov 17, 2026)$20.78

    Key Dates

    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 5.52% in the quarter ended Sep 30, 2026 and grew 19.78% a year over 2 years.

    Shares Outstanding69.90M
    Shares Change (YoY)+19.46%
    Shares Change (QoQ)+5.52%
    Share Count Growth (2Y CAGR)+19.78%

    Valuation Ratios

    Sales and book value multiples are 72.0x and 4.9x. Its year-end P/S ranged from 1.8x to 383.5x from 2016 to 2025.

    P/S Ratio72.0x
    Forward P/S79.6x
    P/B Ratio4.9x
    P/TBV Ratio7.0x

    Valuation history and multiples

    Price Statistics

    The stock is down 30.46% over 52 weeks and trades 27.22% below its 50-day average.

    Beta (1Y)0.98
    52-Week Change-30.46%
    1-Month Change-6.40%
    3-Month Change-57.38%
    6-Month Change-15.84%
    5-Year Change-18.51%
    10-Year Change+265.68%
    Total Return (1Y)-30.46%
    Total Return (3Y CAGR)+44.47%
    Total Return (5Y CAGR)-6.61%
    Return vs SPY (1Y)-41.62%
    Max Drawdown (1Y)-70.23%
    Max Drawdown (3Y)-87.21%
    Sharpe Ratio (1Y)-0.29
    Correlation with SPY (1Y)0.11
    50-Day Average$28.55
    200-Day Average$29.62
    52-Week Range$8.73 to $51.72
    RSI (14 Days)36.5
    Average Volume (20 Days)1.94M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 11.52x current liabilities, and total debt is 0.17x shareholder equity.

    Current Ratio11.52x
    Quick Ratio11.52x
    Debt / Equity0.17x
    Interest Coverage-3.48x

    Returns and Efficiency

    Return on invested capital is -57.88% over the last 12 months, against a 5-year average of -28.69%.

    Return on Equity (ROE)-79.04%
    Return on Assets (ROA)-24.76%
    Return on Invested Capital (ROIC)-57.88%
    Return on Capital Employed (ROCE)-22.77%
    ROA (5Y Average)-16.30%
    ROIC (5Y Average)-28.69%
    Asset Turnover0.02x
    Receivables Turnover3.81x

    Scores

    QURE has an Altman Z-Score of -0.80, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score-0.80
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $20.17M over the last 12 months is up 28.04% from the 12 months before.

    Revenue$20.17M
    Revenue Growth (YoY)+28.04%
    Gross Profit$18.93M
    Operating Income-$202.02M
    Pretax Income-$233.81M
    Net Income-$232.90M
    EBIT-$200.47M
    Reported EPS (TTM)-$3.30

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 31.33% of the $940.55M in total assets.

    Cash and Equivalents$98.44M
    Total Debt$50.34M
    Net Cash$48.10M
    Net Cash Per Share$0.69
    Working Capital$632.40M
    Shareholder Equity$294.65M
    Book Value Per Share$4.22
    Tangible Book Value$208.29M
    Tangible Book Per Share$2.98
    Total Assets$940.55M
    Total Liabilities$645.90M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $742.00K of capital spending, operating cash flow left -$192.96M of free cash flow.

    Operating Cash Flow-$192.22M
    Capital Expenditures$742.00K
    Free Cash Flow-$192.96M
    FCF Per Share-$2.78
    Depreciation and Amortization$34.25M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -1001.74%.

    Gross Margin93.85%
    Operating Margin-1001.74%
    Pretax Margin-1159.36%
    Net Margin-1154.84%
    EBIT Margin-994.04%
    FCF Margin-956.80%
    Gross Margin (5Y Average)95.70%

    Growth

    Revenue fell 46.73% a year over 3 years.

    Revenue Growth (3Y CAGR)-46.73%
    Revenue Growth (5Y CAGR)-15.57%
    Book Value Per Share Growth (2Y CAGR)-10.74%
    Tangible Book Per Share Growth (2Y CAGR)-16.71%

    Revenue and profit by year

    Dividends and Yields

    QURE does not pay a dividend. Its free cash flow yield is -13.28%.

    FCF Yield-13.28%
    Buyback Yield-0.76%
    Shareholder Yield-0.76%

    Peer Position

    Against 10 similar companies, QURE has the 2nd highest P/S.

    P/S Ratio72.0x vs 6.2x median
    ROIC-57.88% vs -34.36% median
    Revenue Growth (Trailing 4 Quarters, YoY)+28.04% vs +18.42% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 143.34% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+143.34%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About QURE

    What is QURE's market cap?

    Uniqure NV has a market cap of $1.53B. Its enterprise value, which adds debt and subtracts cash, is $1.49B.

    How many shares of QURE are outstanding?

    Uniqure NV has 69.90M shares outstanding. The count is up 19.46% from a year earlier.

    Does QURE pay a dividend?

    No. Uniqure NV does not pay a dividend.

    How much debt does QURE have?

    Uniqure NV has $50.34M of total debt and $98.44M of cash and equivalents, a net cash position of $48.10M.